GO
Loading...

Perrigo Co

More

  • U.S. stock index futures ticked lower on Monday, ahead of the Federal Reserve meeting and another heavy week for second quarter earnings.

  • Ben Bernanke the M&A banker? Monday, 29 Jul 2013 | 8:57 AM ET

    The Federal Reserve's taper talk may have rattled the financial markets but it has had one notable beneficiary: Mergers and acquisitions.

  • US drugmaker Perrigo to buy Ireland's Elan Monday, 29 Jul 2013 | 2:43 AM ET

    U.S. generic drugmaker Perrigo agreed to buy fellow drug company Elan for $8.6 billion on Monday in a deal that will hand it royalty rights from a blockbuster treatment and tax savings from being domiciled in Ireland.

  • Perrigo CEO Joe Papa discusses the biotech industry, the state of the consumer and why Mucinex is going to be a big winner for his company.

  • Cramer’s Trend Watch: Store Brands Thursday, 9 May 2013 | 6:14 PM ET

    As the economy stalled, many people opted for store brand medicines. But as the economy improves, will the trend reverse?

  • Greenberg: It's the Stocks You Don't Own That Matter Thursday, 31 Jan 2013 | 8:17 AM ET

    The Forensic Accounting ETF launches today. The fund spotlights a concept that is often woefully overlooked.

  • Perrigo gets FDA OK to sell nicotine lozenges Wednesday, 10 Oct 2012 | 1:56 PM ET

    ALLEGAN, Mich.-- Perrigo Co., which makes store-brand over-the-counter drugs and infant formulas, said Wednesday that it received approval from the U.S. Food and Drug Administration to market an over-the-counter nicotine product similar to Nicorette mini lozenges.

  • *Receives FDA approval to market mini nicotine lozenges.

  • You’ve heard about all those big stocks that you should buy, but the pros say there are plenty of mid-size names that belong on your radar too.

  • Perrigo CEO on Earnings Beat Wednesday, 8 Feb 2012 | 7:39 PM ET

    Perrigo CEO Joseph Papa appeared on Wednesday's "Mad Money."

  • Perrigo CEO on Earnings Beat     Wednesday, 8 Feb 2012 | 6:45 PM ET

    Perrigo CEO, Joseph Papa discusses his company's 11% Q2 profit rise, and its outlook on growth, with Mad Money's Jim Cramer.

  • Perrigo's CEO on Earnings     Thursday, 27 Oct 2011 | 2:35 PM ET

    A breakdown of better-than-expected earnings from the generic drug maker, with Joseph Papa, Perrigo CEO.

  • Cramer: Do Your Homework Wednesday, 19 Oct 2011 | 6:15 PM ET

    A lot of people aren’t doing their homework and those people are losing money.

  • How Investors Can Diversify When Markets Move Together Friday, 14 Oct 2011 | 12:46 PM ET

    When it comes to combating financial markets that all seem to move in unison, the options are getting so limited that some are questioning whether stock picking is a dying art.

  • Stock Picking by the Individual Investor Isn't Dead Thursday, 13 Oct 2011 | 3:34 PM ET

    Cramer and his researcher, Nicole Urken, discuss why homework—particularly during earnings season—remains important to recognizing the stock winners of the coming years.

  • Perrigo CEO: Why Business is Growing Tuesday, 27 Sep 2011 | 6:42 PM ET

    Joseph Papa sits down with Cramer and explains why things are looking good for the private label drug maker.

  • Perrigo CEO Talks China Biz     Tuesday, 27 Sep 2011 | 6:15 PM ET

    Mad Money host Jim Cramer takes a look at Perrigo, which develops, manufactures and distributes private label goods to retailers. Joseph Papa, chairman, president & CEO of Perrigo, weighs in. "Our products are popular in both bull and bear markets," he says.

  • Perrigo Rising     Wednesday, 7 Sep 2011 | 1:35 PM ET

    Does Perrigo still have room to run? Shares of the recession-resistant business are up about 45 percent and among the top ten S&P 400 midcap stocks, with Linda Bolton Weiser, Caris & Company managing director.

  • Cramer: Trading the Euro Zone Debt Crisis Tuesday, 16 Aug 2011 | 6:28 PM ET

    The “Mad Money” host explains why Europe’s problems trump good news out of the US.

  • The 7 Things Cramer's Watching Tuesday Monday, 15 Aug 2011 | 6:45 PM ET

    There's a lot going on in this volatile market, but Cramer thinks it's important to monitor the following things in particular.

Most Popular Video

Friday, 18 Apr 2014 | 12:00 PM ET

CNBC's Stephanie Landsman discusses how the luxury rental boom isn't confined to New York City and its boroughs, but that developers are seeing new opportunities in New Jersey.

Thursday, 17 Apr 2014 | 12:00 PM ET

CNBC's Josh Lipton and Allison+Partners Head of Digital Jeremy Rosenberg discuss what Microsoft needs to do to boost Xbox One sales as PS4 sales break the 7 million mark.

Thursday, 17 Apr 2014 | 4:13 PM ET

Dissecting today's market activity and the current state of financials, with Yra Harris, Praxis Trading partner; Larry Glazer, Mayflower Advisors; CNBC contributor Carol Roth; "Fast Money" Guy Adami and CNBC's Kate Kelly.